NevadaSB24483rd Regular Session (2025)SenateWALLET

AN ACT relating to Medicaid; requiring Medicaid to cover certain treatments for obesity and the services of certain programs for the prevention of diabetes; and providing other matters properly relating thereto.

Sponsored By: Michelee "Shelly" Cruz-Crawford (Democratic), Roberta Lange (Democratic), Rochelle T. Nguyen (Democratic)

Failed

BDR 38-206

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Nevada Medicaid adds diabetes prevention coverage

Beginning January 1, 2026, Nevada Medicaid covers qualifying diabetes prevention programs, subject to available federal funding. Recipients must meet program eligibility requirements and must not have previously participated in a diabetes prevention program while enrolled in Medicaid. Programs provide structured behavior-change sessions to help prevent or delay type II diabetes. Providers must be recognized by the Diabetes Prevention Recognition Program and use a CDC-approved curriculum.

Nevada Medicaid adds more obesity treatment

Beginning January 1, 2026, Nevada Medicaid covers intensive obesity treatment, qualifying surgery, and qualifying weight-management drugs, subject to available federal funding. Intensive treatment combines health, behavior, and lifestyle support, meets current CDC-recognized or clinical standards, and includes in-person or telehealth care. Surgery must be listed in the latest guidelines from the American and international metabolic and bariatric surgery groups. Covered drugs must be FDA-approved for chronic weight management in people diagnosed with obesity and prescribed for their approved uses. Medicaid must also include these qualifying drugs on its preferred drug list.

Sponsors & Cosponsors

Sponsors

  • Michelee "Shelly" Cruz-Crawford

    Democratic • Senate

  • Roberta Lange

    Democratic • Senate

  • Rochelle T. Nguyen

    Democratic • Senate

Cosponsors

  • Angela D. Taylor

    Democratic • Senate

  • Edgar Flores

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Bill Text

  • As Introduced

Related Bills

Back to State Legislation